Hamid, A., Guilhaus, M., Azad, A., Rehn, J., Grist, E., Kwan, E. M., Subhash, V., Oakes, S. R., Kench, J. G., AlDubayan, S., Allen, E. M. V., Stockler, M. R., Wyatt, A. W., Attard, G., Horvath, L., Davis, I. D., Sweeney, C. (2026). Germline genetic correlates in metastatic hormone-sensitive prostate cancer (mHSPC) treated with androgen deprivation therapy (ADT) plus non-steroidal anti-androgen (NSAA) or enzalutamide (ENZA): Correlative study of ENZAMET (ANZUP 1304).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5099